Plasma Fibrinogen Qualification as a Drug Development Tool in Chronic Obstructive Pulmonary Disease. Perspective of the Chronic Obstructive Pulmonary Disease Biomarker Qualification Consortium
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Plasma Fibrinogen Qualification as a Drug Development Tool in Chronic Obstructive Pulmonary Disease. Perspective of the Chronic Obstructive Pulmonary Disease Biomarker Qualification Consortium
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
Volume 193, Issue 6, Pages 607-613
Publisher
American Thoracic Society
Online
2016-01-09
DOI
10.1164/rccm.201509-1722pp
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Circulating Soluble Receptor for Advanced Glycation End Products (sRAGE) as a Biomarker of Emphysema and the RAGE Axis in the Lung
- (2015) John G. Yonchuk et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Biomarkers for precision medicine in airways disease
- (2015) Claire Rooney et al. Annals of the New York Academy of Sciences
- Building a roadmap to biomarker qualification: challenges and opportunities
- (2015) Shashi G Amur et al. Biomarkers in Medicine
- The PROactive instruments to measure physical activity in patients with chronic obstructive pulmonary disease
- (2015) Elena Gimeno-Santos et al. EUROPEAN RESPIRATORY JOURNAL
- Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials
- (2015) Steven Pascoe et al. Lancet Respiratory Medicine
- Clinical development success rates for investigational drugs
- (2014) Michael Hay et al. NATURE BIOTECHNOLOGY
- The COPD pipeline
- (2014) Yasser Mushtaq NATURE REVIEWS DRUG DISCOVERY
- Patient-reported Outcome (PRO) Measures for Clinical Trials of COPD: The EXACT and E-RS
- (2013) Nancy K. Leidy et al. COPD-Journal of Chronic Obstructive Pulmonary Disease
- The COPD Biomarker Qualification Consortium (CBQC)
- (2013) Richard Casaburi et al. COPD-Journal of Chronic Obstructive Pulmonary Disease
- Novel Anti-Inflammatory Agents in COPD: Targeting Lung and Systemic Inflammation
- (2013) Stelios Loukides et al. CURRENT DRUG TARGETS
- Design of the Subpopulations and Intermediate Outcomes in COPD Study (SPIROMICS): Table 1
- (2013) David Couper et al. THORAX
- Analysis of chronic obstructive pulmonary disease exacerbations with the dual bronchodilator QVA149 compared with glycopyrronium and tiotropium (SPARK): a randomised, double-blind, parallel-group study
- (2013) Jadwiga A Wedzicha et al. Lancet Respiratory Medicine
- Once-daily inhaled fluticasone furoate and vilanterol versus vilanterol only for prevention of exacerbations of COPD: two replicate double-blind, parallel-group, randomised controlled trials
- (2013) Mark T Dransfield et al. Lancet Respiratory Medicine
- Evaluation of losmapimod in patients with chronic obstructive pulmonary disease (COPD) with systemic inflammation stratified using fibrinogen (‘EVOLUTION’): Rationale and protocol
- (2013) M. Fisk et al. Artery Research
- Inflammatory Biomarkers Improve Clinical Prediction of Mortality in Chronic Obstructive Pulmonary Disease
- (2012) Bartolome R. Celli et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Physical activity in COPD patients: patterns and bouts
- (2012) David Donaire-Gonzalez et al. EUROPEAN RESPIRATORY JOURNAL
- Persistent Systemic Inflammation is Associated with Poor Clinical Outcomes in COPD: A Novel Phenotype
- (2012) Alvar Agustí et al. PLoS One
- Blood fibrinogen as a biomarker of chronic obstructive pulmonary disease: Table 1
- (2012) Annelyse Duvoix et al. THORAX
- Efficacy and safety of roflumilast in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis
- (2012) Yuji Oba et al. Therapeutic Advances in Respiratory Disease
- Tiotropium versus Salmeterol for the Prevention of Exacerbations of COPD
- (2011) Claus Vogelmeier et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genetic Epidemiology of COPD (COPDGene) Study Design
- (2010) Elizabeth A. Regan et al. COPD-Journal of Chronic Obstructive Pulmonary Disease
- The Many “Small COPDs”
- (2008) Stephen I. Rennard et al. CHEST
- Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE)
- (2008) J. Vestbo et al. EUROPEAN RESPIRATORY JOURNAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More